Zallie James P.

INGR CEO Zallie James sold 9,958 shares at $116.55 on 2026-02-18; current price $116.54, -17.3% from 52-week high.

CEO Zallie James P. sold 9,958 shares (-23.2% vs pre-transaction holdings), reducing his stake from 42,968 to 33,010 shares. At a sale price of $116.55, this aligns closely with the current market price of $116.54, though the stock remains -17.3% below its 52-week high of $140.95. His prior trades at Ingredion show mixed outcomes: 4 of 5 prior sells had measurable 90-day returns, with only 1 well-timed (negative 90d return). His cross-ticker track record shows an average 90-day return of +5.9% after sells, with a 14.29% well-timed rate—a modest pattern. The company trades at a P/E of 9.90 with recent annual revenue declining -2.8%, suggesting modest valuation amid soft top-line trends. The sale timing—just 7 days after his prior sell on 2026-02-11—warrants attention as a potential signal of ongoing disposition activity by the CEO.

INGR CEO Zallie James P. sold 33,597 shares at $119.66 (Feb 2026); stock down 16.8% from 52-week high, revenue declined 9.0% YoY.

Zallie James P., President and CEO, sold 33,597 shares (33.6K shares) at $119.66 on 2026-02-11, reducing his holding from 83,763 shares to 50,166 shares—a -40.1% reduction in his position. The sale occurred when INGR was trading 16.8% below its 52-week high of $140.95, and the company is facing a -9.0% annual revenue decline. His prior five sales at INGR show only 1 of 5 were well-timed by the 90-day standard, with an average 90-day return of +4.4%, suggesting his sales historically have not preceded major declines. The substantial reduction in CEO equity stake at a depressed relative price warrants monitoring of the company's operational outlook and capital allocation decisions going forward.

INGR CEO Zallie James P. sold 36,287 shares at $126.52 on 2025-08-12; stock now -18.4% from 52-week high.

Zallie James P., President and CEO of Ingredion Inc, sold 36,287 shares (36.3K shares) for $4,591,140.10 ($4.6M), reducing holdings by -42.0% from 86,415 to 50,128 shares. The transaction occurred at $126.52 on 2025-08-12, when the stock was already -5.9% over 30 days and -10.2% over 90 days; it has since declined further to -18.4% from the 52-week high of $154.86. His prior 5 sells at INGR showed an average 90-day return of +9.6%, with 0 of 5 timed ahead of actual declines—indicating these sales preceded rallies rather than downturns. This sale differs materially: the stock continued falling post-transaction rather than rising. The company's revenue growth is -9.0% year-over-year despite a low P/E of 12.00, and cash generation (net income $196.0M on $1.8B revenue) remains healthy. The large reduction in CEO holdings warrants monitoring given the deteriorating price action and negative growth trajectory, though the sale's timing relative to the sustained decline may reflect internal circumstances rather than a pattern of market-timed exits.

CEO Zallie James P. sold 10,815 shares of INGR at $125.88 on 2025-02-19 for $1.4M, reducing stake by 24.1%.

CEO Zallie James P. executed a substantial sale, reducing his holdings from 44.9K to 34.1K shares in a single transaction. The timing occurs as INGR trades -18.4% from its 52-week high and -7.4% over the past 30 days, following a -9.0% annual revenue decline. His prior trades at INGR show a mixed pattern: 0 of 4 prior measurable sales were well-timed at the 90-day mark, with outcomes ranging from -2.9% to +15.4% in the 90-day window post-sale. The current sale represents a material disposition of executive equity, occurring in a period of both stock weakness and revenue headwinds, though without scheduled trading plan disclosure this remains discretionary.

Ingredion CEO Zallie James P. sold 39,329 shares (39.3K) for $4,991,046.75 ($5.0M) on 2025-02-14 at $126.90

Zallie James P., President and CEO, divested 39,329 shares at $126.90 on 2025-02-14, reducing his stake from 92,086 shares to 52,757 shares—a -42.7% reduction in post-transaction holdings. The sale occurred as the stock trades 18.9% below its 52-week high of $154.86, with 30-day and 90-day declines of -7.0% and -11.8% respectively. At the same-ticker level, his prior four INGR sales generated positive 90-day average returns of +8.9% (ranging from +0.3% to +15.4%), indicating that prior transactions were poorly timed relative to subsequent price performance. The current fundamentals remain intact: $1.9B quarterly revenue, 11.98 P/E ratio, and +2.7% annual revenue growth. This sale represents a substantial reduction in CEO exposure during a period of price weakness and follows a pattern of prior sales that did not precede meaningful declines.

CEO Zallie James P. sold 22,550 shares of INGR at $134.14 (8/30); stock at 52-week high, prior two INGR sells underperformed (negative 90d returns).

Zallie James P., President and CEO, executed a sale of 22,550 shares on 2024-08-30 at $134.14, reducing his holdings by 30.0% from 75,080 to 52,530 shares and generating $3,024,834.45 in proceeds. The transaction occurred at a price level within 0.0% of the 52-week high of $134.31, at the peak of a 9.2% 30-day rally and 15.9% 90-day surge. Examining his prior trades at INGR, two completed sales on 2024-06-03 and 2024-03-04 exhibited 90-day returns of +15.4% and +0.3% respectively, indicating neither sale preceded a material stock decline—a pattern inconsistent with well-timed exit execution. The company trades at a P/E of 13.38 on $1.9B quarterly revenue with $148.0M net income, providing no immediate fundamental distress signal. The simultaneous sale on 2024-08-29 (outcome not yet measurable) combined with this sale of 22.6K shares suggests sustained capital redeployment at peak valuations.

CEO Zallie James P. sells 3,981 shares of INGR at $134.02 for $533.5K; stock near 52-week high

CEO Zallie James P. sold 3,981 shares (4.0K shares) of Ingredion at $134.02 on 2024-08-29, reducing holdings from 56,511 to 52,530 shares. The sale occurred at a price very close to the current 52-week high of $134.31, with the stock up 8.0% over the prior 30 days and up 14.2% over 90 days. His prior open-market sell history across all tickers shows modest negative timing (avg 90d return +0.3%, 0% well-timed rate), and at INGR specifically, prior sells have trended slightly negative at the 30-day mark (-2.9%, -2.4%). The company's fundamentals remain solid with $1.9B in quarterly revenue and a P/E of 13.38. The transaction represents a 7.0% reduction in his holdings and occurs after a sustained period of stock appreciation.